NCT03038334View on ClinicalTrials.gov

Magnesium Sulfate for the Improvement of Cognition in Patients With Alzheimer Disease

NAUnknownINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

February 20, 2017

Primary Completion Date

August 20, 2019

Study Completion Date

October 20, 2019

Conditions
Alzheimer Disease
Interventions
DIETARY_SUPPLEMENT

Magnesium sulfate

Transdermal application of Magnesium sulfate 250mg every four hours per day for 90 days.

Sponsors
All Listed Sponsors
lead

Metabolic Therapy Inc.

OTHER